ArticleSurgical case reports2020

Mixed adenoneuroendocrine carcinoma with loss of HER2 positivity after trastuzumab-based chemotherapy for HER2-positive gastric cancer: a case report.

Hiromi Nagata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.